Latest Breaking News On - Tumor microenvironment targeting technology - Page 1 : vimarsana.com

Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of SPLASH trial ongoing, top line data expected.

United statesUnited kingdomRobin hallettBach biosciencesSherin al safadiJoe mccannNeil fleshnerJonathan ross goodmanDaniel pearlsteinMatthew vincentUniversity health networkBelgian nuclear research centerKinectrics incTumor microenvironment targeting technologyCentre for probe developmentTranslational sciences